(Q24306910)
Statements
Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation (English)
0 references
16 November 2010
0 references
18
0 references
423-35
0 references
5
0 references
1 reference
1 reference
1 reference
1 reference